Health Care

Richard Scrushy said he is looking forward to having the rest of his corruption charges thrown out by the Supreme Court.

Eli Lilly reported an adjusted 4Q profit of $0.78 per share, matching the estimate. Revenue for the drugmaker came in at $5.38 billion, beating the estimate for $5.3 billion.

Health insurer Anthem reported a net profit that fell short of analysts' estimates, hampered by weakness in its Obamacare business.

Health insurer WellPoint could have its pick of several industry executives to replace CEO Angela Braly who's exit from the company was announced late Tuesday night. 

Boston Scientific is reportedly planning on reversing at least some of the restructuring put in place by its former CEO by separating the two main divisions of its biggest business and is preparing another round of job cuts.

Medtronic was granted approval for a new device used to treat paroxysmal atrial fibrillation.

Sunrise Senior Living is in a $845 million deal to be purchased by Health Care REIT.

Criticism is intensifying about the second-largest U.S. health insurer’s poor stock performance, weak quarterly earnings and bleak outlook that includes a predicted loss of some 900,000 members, leading calls for the ouster of CEO Angela Braly.

AstraZeneca hired Pascal Soriot from rival Roche to be its new chief executive, hoping his veteran experience helps revive the drugmaker.

Aetna is buying rival Coventry Health Care for $5.7 billion to build its Medicare business.

With the prevalence of diabetes growing at a quick pace and health-care reform that could widen access to insurance for millions of people looming, a bitter battle among drug makers is intensifying. 

Amylin Pharmaceuticals shares rose as much as 51% on Wednesday on reports that the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb.

Johnson & Johnson forecast 2016 sales below analysts' estimate and reported a 2.4 percent drop in sales for the fourth quarter, hurt by a strong dollar.

Johnson & Johnson is set to pay more than $1 billion to resolve a civil investigation into the marketing of its Risperdal antipsychotic drug.

UnitedHealth projected a 5% increase in 2013 earnings, but Wall Street had been anticipating stronger growth from the largest U.S. private health insurer.

The Supreme Court on Monday revived a legal challenge to President Obama's Affordable Care Act filed by Liberty University on religious grounds.